BeOne Medicines AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4,792	4,548	2,627	3,172	3,870	4,376
Short-Term Investments	-	-	-	-	665.25	2,245
Cash & Short-Term Investments	4,792	4,548	2,627	3,172	4,535	6,621
Cash Growth	90.42%	73.08%	-17.16%	-30.06%	-31.50%	42.36%
Accounts Receivable	938.02	865.08	676.28	358.03	173.17	483.11
Other Receivables	10.35	21.78	32.83	37.86	25.82	17.06
Receivables	948.36	886.86	709.11	395.89	198.98	500.18
Inventory	681.59	608.23	494.99	416.12	282.35	242.63
Prepaid Expenses	34.48	55.93	49.37	88.26	83.09	138.81
Restricted Cash	40.84	41.28	9.31	11.47	0.2	0.33
Other Current Assets	104.34	93.76	101.41	119.88	107.65	111.32
Total Current Assets	6,601	6,234	3,992	4,203	5,207	7,614
Property, Plant & Equipment	1,786	1,790	1,718	1,419	955.91	705.04
Long-Term Investments	65.99	61.68	128.93	89.64	91.78	100.79
Goodwill	-	-	-	-	-	0.11
Other Intangible Assets	61.68	62.7	51.1	57.14	40.62	46.68
Other Long-Term Assets	38.26	40.74	31.56	35.72	83.91	69.03
Total Assets	8,554	8,189	5,921	5,805	6,379	8,536
Accounts Payable	423.55	479.04	405	315.11	294.78	262.4
Accrued Expenses	866.57	961.09	780.48	624.92	480.1	534.33
Short-Term Debt	67.91	9.06	816.95	659.79	314.83	424.74
Current Portion of Long-Term Debt	120.97	104.94	34.58	28.58	14.14	2.82
Current Portion of Leases	20.58	20.7	17.58	21.95	24.04	21.93
Current Income Taxes Payable	63.52	41.63	25.93	22.95	25.19	21.4
Current Unearned Revenue	-	-	-	-	213.86	187.41
Other Current Liabilities	248.42	212.37	134.39	136.82	101.59	144.53
Total Current Liabilities	1,812	1,829	2,215	1,810	1,469	1,600
Long-Term Debt	1,794	1,812	166.48	197.62	209.15	202.11
Long-Term Leases	49.67	52.94	44.28	22.25	34.52	43.04
Long-Term Unearned Revenue	28.72	28.98	30.32	34.2	80.2	266.64
Pension & Post-Retirement Benefits	18.26	18.17	16.41	15	7.76	7.81
Long-Term Deferred Tax Liabilities	55.87	53.21	42.01	16.49	16	14.17
Other Long-Term Liabilities	34.97	33.1	74.29	172.27	179.78	269.63
Total Liabilities	3,793	3,827	2,589	2,268	1,996	2,403
Common Stock	0.14	0.14	0.14	0.14	0.14	0.13
Additional Paid-In Capital	12,906	12,759	12,088	11,599	11,541	11,191
Retained Earnings	-8,093	-8,320	-8,607	-7,962	-7,080	-5,077
Comprehensive Income & Other	-53.48	-78.18	-148.99	-99.45	-77.42	17.95
Total Common Equity	4,760	4,361	3,332	3,537	4,383	6,133
Shareholders' Equity	4,760	4,361	3,332	3,537	4,383	6,133
Total Liabilities & Equity	8,554	8,189	5,921	5,805	6,379	8,536
Total Debt	2,053	2,000	1,080	930.19	596.68	694.64
Net Cash (Debt)	2,738	2,548	1,548	2,242	3,938	5,926
Net Cash Growth	80.20%	64.63%	-30.96%	-43.08%	-33.54%	44.94%
Net Cash Per Share	23.90	22.46	14.70	21.47	38.19	63.87
Filing Date Shares Outstanding	111.17	110.94	106.72	104.58	104.32	102.68
Total Common Shares Outstanding	111.11	110.85	106.72	104.58	104.32	102.68
Working Capital	4,790	4,405	1,777	2,393	3,739	6,014
Book Value Per Share	42.84	39.34	31.22	33.82	42.02	59.73
Tangible Book Value	4,699	4,298	3,281	3,480	4,343	6,086
Tangible Book Value Per Share	42.29	38.78	30.75	33.28	41.63	59.27
Land	71.43	71.43	65.49	65.49	65.49	65.49
Buildings	1,197	1,188	607.86	231.66	222.45	144.08
Machinery	602.01	583.24	485.14	392.21	334.59	237.79
Construction In Progress	137.45	127.16	654.02	740.62	293.63	186.84
Leasehold Improvements	77.18	76.57	64.68	60.12	53.79	50.29